LONG-term exposure to low-level traffic-derived air pollution causes liver inflammation, fibrosis, and metabolic changes ...

Polystyrene microplastics — as well as nanoplastics, which are categorically smaller than microplastics — are showing up in ...

Drinking alcohol significantly increases the risk of advanced liver disease in people with diabetes, high blood pressure, or ...

Nearly 4 in 10 American adults are estimated to have a liver condition that can lead to serious complications and even death.

Elevated fat levels in your liver can raise your chances of developing serious health issues, including diabetes, ...

Findings from a new Dartmouth-led study, published in the journal mBio, highlight key differences in the gut microbiome (communities of bacteria) of infants with cystic fibrosis (CF) compared to that ...

Raichur: Shilpa Medicare Limited, recently announced that its Investigational New Drug (IND), Nor-Ursodeoxycholic Acid ...

Scientists have uncovered a strong link between zinc levels in the human body and the risk of developing type 2 diabetes and ...

Primary Biliary Cholangitis Clinical Trial Pipeline Pharmaceutical companies are advancing the Primary Biliary Cholangitis treatment pipeli ...

The trials identified no serious adverse effects, and patients tolerated a daily dosage of 1500 mg for 24 weeks.

Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on ...

Shilpa Medicare announces the approval of its IND - Nor Ursodeoxycholic Acid Tablets 500 mg, by the Subject Expert Committee of CDSCO. The Committee has further recommended grant of marketing ...